- Home
- SLGL
as of 12-19-2025 3:42pm EST
$42.02
$0.73
-1.71%
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
Chart Type:
Time Range:
| Founded: | 1997 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 117.8M | IPO Year: | 2018 |
| Target Price: | $50.00 | AVG Volume (30 days): | 15.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.02 - $52.26 | Next Earning Date: | 11-20-2025 |
| Revenue: | $18,970,000 | Revenue Growth: | 62.04% |
| Revenue Growth (this year): | 121.82% | Revenue Growth (next year): | -78.96% |
Stock Insider Trading Activity of Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc.
Buy
10% Owner
SLGL Dec 12, 2025
Avg Cost/Share
$40.00
Shares
87
Total Value
$3,480.00
Owned After
371,795
SEC Form 4
Opaleye Management Inc.
Buy
10% Owner
SLGL Dec 8, 2025
Avg Cost/Share
$39.78
Shares
300
Total Value
$11,932.50
Owned After
371,795
SEC Form 4
Opaleye Management Inc.
Buy
10% Owner
SLGL Dec 5, 2025
Avg Cost/Share
$39.50
Shares
444
Total Value
$17,536.80
Owned After
371,795
SEC Form 4
Opaleye Management Inc.
Buy
10% Owner
SLGL Dec 3, 2025
Avg Cost/Share
$37.81
Shares
2,524
Total Value
$95,443.04
Owned After
371,795
SEC Form 4
Opaleye Management Inc.
Buy
10% Owner
SLGL Dec 1, 2025
Avg Cost/Share
$37.37
Shares
4,340
Total Value
$162,166.70
Owned After
371,795
SEC Form 4
Opaleye Management Inc.
Buy
10% Owner
SLGL Nov 26, 2025
Avg Cost/Share
$40.00
Shares
943
Total Value
$37,720.00
Owned After
371,795
SEC Form 4
Opaleye Management Inc.
Buy
10% Owner
SLGL Nov 24, 2025
Avg Cost/Share
$35.50
Shares
6
Total Value
$213.00
Owned After
371,795
SEC Form 4
Opaleye Management Inc.
Buy
10% Owner
SLGL Nov 20, 2025
Avg Cost/Share
$35.83
Shares
5,784
Total Value
$207,243.61
Owned After
371,795
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 12, 2025 | Buy | $40.00 | 87 | $3,480.00 | 371,795 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 8, 2025 | Buy | $39.78 | 300 | $11,932.50 | 371,795 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 5, 2025 | Buy | $39.50 | 444 | $17,536.80 | 371,795 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 3, 2025 | Buy | $37.81 | 2,524 | $95,443.04 | 371,795 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 1, 2025 | Buy | $37.37 | 4,340 | $162,166.70 | 371,795 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Nov 26, 2025 | Buy | $40.00 | 943 | $37,720.00 | 371,795 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Nov 24, 2025 | Buy | $35.50 | 6 | $213.00 | 371,795 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Nov 20, 2025 | Buy | $35.83 | 5,784 | $207,243.61 | 371,795 |
Latest Sol-Gel Technologies Ltd. News
SLGL Breaking Stock News: Dive into SLGL Ticker-Specific Updates for Smart Investing
GlobeNewswire
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
📉
AI Sentiment
Negative
2/10
Compare SLGL vs Leading Stocks
See how SLGL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SLGL Sol-Gel Technologies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.